Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ARTL

ARTL News

Newswire

08:51

Artelo Biosciences shares surge 39.36% premarket after peer-reviewed study shows FABP5 inhibitor reduces stress-related behaviors in preclinical trials.

08:34

Artelo Biosciences' SBFI103 shows anxiolytic and antidepressant effects in preclinical model.

08:30

Artelo Biosciences Announces FABP5 Inhibitor Study Demonstrating Anxiety and Depression Reductions in Preclinical Models.

11:02

Artelo Biosciences: Maxim Group Downgrades Hold from Buy

08:04

Artelo Biosciences advances three programs, sees partnering interest.

View More

About ARTL

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More